When you hear the term “monster movies,” you might think you know what to expect. A giant, irradiated bug stomping all over a modern metropolis, perhaps, or an inhuman beast stalking a group of ...

A shattered kingdom with you as the chosen one to bring it back to its glory while redeeming corrupted maidens and evolving them as they fight for you—what’s not to love in this game? All that’s left ...

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...